GITNUXREPORT 2025

Dermatology Statistics

Dermatology market surpasses $16 billion, driven by aesthetic and skin cancer treatments.

Jannik Linder

Co-Founder of Gitnux, specialized in content and tech since 2016.

First published: April 29, 2025

Our Commitment to Accuracy

Rigorous fact-checking • Reputable sources • Regular updatesLearn more

Statistic 1

Female patients are more likely to seek dermatological care for cosmetic procedures, representing approximately 80% of cosmetic dermatology patients

Statistic 2

The number of cosmetic dermatology procedures worldwide reached over 20 million in 2022

Statistic 3

Approximately 70% of cosmetic dermatology patients seek treatments for anti-aging purposes

Statistic 4

Approximately 50% of all dermatological consultations in the U.S. are related to cosmetic concerns

Statistic 5

The cost of laser tattoo removal ranges from $200 to $500 per session, with an average of 5-8 sessions per removal

Statistic 6

Skin cancer accounts for nearly 40% of all cancers diagnosed in the United States

Statistic 7

Acne affects approximately 85% of people at some point in their lives

Statistic 8

Melanoma is responsible for the majority of skin cancer deaths, despite being less common than other skin cancers

Statistic 9

Psoriasis affects about 2-3% of the global population

Statistic 10

The prevalence of atopic dermatitis in children worldwide is around 15-20%

Statistic 11

Approximately 10% of Americans experience some form of eczema

Statistic 12

The incidence of non-melanoma skin cancer has increased by about 77% in the United States over the last decade

Statistic 13

About 1 in 5 Americans will develop skin cancer at some point in their lifetime

Statistic 14

The average age of skin cancer diagnosis is 65 years old

Statistic 15

The prevalence of vitiligo is approximately 0.5-1% of the world population

Statistic 16

Melasma affects about 6 million Americans, primarily women

Statistic 17

The majority of patients with hidradenitis suppurativa are between ages 20 and 40

Statistic 18

About 80% of people with rosacea are between the ages of 30 and 50

Statistic 19

The incidence of atopic dermatitis has been rising globally, with some countries experiencing a 50% increase over the last 20 years

Statistic 20

Melanocytic nevus (mole) prevalence is about 20-50% in adults, depending on age and skin type

Statistic 21

Basal cell carcinoma accounts for about 80% of non-melanoma skin cancers

Statistic 22

The rate of hard-to-treat fungal skin infections has increased globally by approximately 30% over the last five years

Statistic 23

Pediatric patients account for roughly 20% of dermatology clinic visits annually in the U.S.

Statistic 24

The prevalence of seborrheic dermatitis is estimated at 1-5% worldwide, with higher rates in immunocompromised individuals

Statistic 25

The highest prevalence of psoriasis occurs in Scandinavia, with rates up to 11.4% in Norway

Statistic 26

The percentage of pregnant women who develop melasma ranges from 50% to 70%, especially in regions with high sun exposure

Statistic 27

Contact dermatitis affects nearly 3 million people in the U.S. annually, making it one of the most common skin conditions

Statistic 28

About 33% of people with psoriasis experience joint pain, indicating psoriatic arthritis

Statistic 29

The prevalence of rosacea is higher in individuals with fair skin, with studies showing up to 10% prevalence in these populations

Statistic 30

About 15% of all skin cancer diagnoses are in people under age 40, emphasizing early screening importance

Statistic 31

The global dermatology market was valued at approximately $16.4 billion in 2022

Statistic 32

Laser skin resurfacing procedures increased by 5% globally in 2022

Statistic 33

The use of biologic drugs for psoriasis treatment has increased by over 250% in the last decade

Statistic 34

The global market for anti-aging dermatology products is projected to reach $14 billion by 2027

Statistic 35

Augmentation of the lips with fillers has increased by 60% globally from 2020 to 2022

Statistic 36

The global market for medical dermatology drugs was valued at around $10 billion in 2021

Statistic 37

The number of dermatology apps increased by over 300% during the COVID-19 pandemic, reflecting a shift towards teledermatology

Statistic 38

The market for laser therapy devices in dermatology is projected to reach $2.2 billion by 2025

Statistic 39

There is an increasing trend of using cosmeceuticals in dermatology, with the global market expected to reach $55 billion by 2025

Statistic 40

The average waiting time for dermatology appointments in the U.S. is about 30 days, often leading patients to seek alternative solutions

Statistic 41

The global dermatology-related telemedicine market is expected to grow at a CAGR of 16% from 2022 to 2030

Statistic 42

The global anti-aging dermatology market is projected to grow at a CAGR of approximately 7% from 2023 to 2030, reaching over $25 billion

Statistic 43

The global market for clinical dermatology devices is expected to reach $3 billion by 2025, driven largely by advances in aesthetic treatments

Statistic 44

The use of chemical peels increased by 20% during the COVID-19 pandemic, as patients sought non-invasive anti-aging treatments

Statistic 45

UV exposure increases the risk of melanoma by approximately 20 times in individuals who have had significant sunburns

Statistic 46

The use of sunscreens with SPF 30 or higher can reduce skin cancer risk by approximately 50%

Statistic 47

The average cost of treating actinic keratosis in the U.S. ranges from $150 to $400 per lesion

Statistic 48

The use of topical corticosteroids is one of the most common dermatological treatments, with over 250 million prescriptions annually in the U.S.

Statistic 49

The use of topical retinoids in dermatology increased by roughly 45% over the last decade, mainly for acne and anti-aging

Slide 1 of 49

Sources

Our Reports have been cited by:

Trust Badges - Publications that have cited our reports

Key Highlights

The global dermatology market was valued at approximately $16.4 billion in 2022
Skin cancer accounts for nearly 40% of all cancers diagnosed in the United States
Acne affects approximately 85% of people at some point in their lives
Melanoma is responsible for the majority of skin cancer deaths, despite being less common than other skin cancers
Psoriasis affects about 2-3% of the global population
The prevalence of atopic dermatitis in children worldwide is around 15-20%
Approximately 10% of Americans experience some form of eczema
Laser skin resurfacing procedures increased by 5% globally in 2022
The incidence of non-melanoma skin cancer has increased by about 77% in the United States over the last decade
About 1 in 5 Americans will develop skin cancer at some point in their lifetime
The use of biologic drugs for psoriasis treatment has increased by over 250% in the last decade
Female patients are more likely to seek dermatological care for cosmetic procedures, representing approximately 80% of cosmetic dermatology patients
The number of cosmetic dermatology procedures worldwide reached over 20 million in 2022

Did you know that the dermatology market soared to a staggering $16.4 billion in 2022, reflecting a global surge in skin health awareness, cosmetic procedures, and innovative treatments?

Cosmetic Procedures and Aesthetic Market

Female patients are more likely to seek dermatological care for cosmetic procedures, representing approximately 80% of cosmetic dermatology patients
The number of cosmetic dermatology procedures worldwide reached over 20 million in 2022
Approximately 70% of cosmetic dermatology patients seek treatments for anti-aging purposes
Approximately 50% of all dermatological consultations in the U.S. are related to cosmetic concerns
The cost of laser tattoo removal ranges from $200 to $500 per session, with an average of 5-8 sessions per removal

Cosmetic Procedures and Aesthetic Market Interpretation

These statistics reveal that women predominantly drive the booming $20-billion global cosmetic dermatology industry—where anti-aging and tattoo removal are top priorities—highlighting a societal shift towards prioritizing appearance, often at a steep price.

Epidemiology and Disease Prevalence

Skin cancer accounts for nearly 40% of all cancers diagnosed in the United States
Acne affects approximately 85% of people at some point in their lives
Melanoma is responsible for the majority of skin cancer deaths, despite being less common than other skin cancers
Psoriasis affects about 2-3% of the global population
The prevalence of atopic dermatitis in children worldwide is around 15-20%
Approximately 10% of Americans experience some form of eczema
The incidence of non-melanoma skin cancer has increased by about 77% in the United States over the last decade
About 1 in 5 Americans will develop skin cancer at some point in their lifetime
The average age of skin cancer diagnosis is 65 years old
The prevalence of vitiligo is approximately 0.5-1% of the world population
Melasma affects about 6 million Americans, primarily women
The majority of patients with hidradenitis suppurativa are between ages 20 and 40
About 80% of people with rosacea are between the ages of 30 and 50
The incidence of atopic dermatitis has been rising globally, with some countries experiencing a 50% increase over the last 20 years
Melanocytic nevus (mole) prevalence is about 20-50% in adults, depending on age and skin type
Basal cell carcinoma accounts for about 80% of non-melanoma skin cancers
The rate of hard-to-treat fungal skin infections has increased globally by approximately 30% over the last five years
Pediatric patients account for roughly 20% of dermatology clinic visits annually in the U.S.
The prevalence of seborrheic dermatitis is estimated at 1-5% worldwide, with higher rates in immunocompromised individuals
The highest prevalence of psoriasis occurs in Scandinavia, with rates up to 11.4% in Norway
The percentage of pregnant women who develop melasma ranges from 50% to 70%, especially in regions with high sun exposure
Contact dermatitis affects nearly 3 million people in the U.S. annually, making it one of the most common skin conditions
About 33% of people with psoriasis experience joint pain, indicating psoriatic arthritis
The prevalence of rosacea is higher in individuals with fair skin, with studies showing up to 10% prevalence in these populations
About 15% of all skin cancer diagnoses are in people under age 40, emphasizing early screening importance

Epidemiology and Disease Prevalence Interpretation

Despite skin cancer constituting nearly 40% of all cancers diagnosed in the U.S. and affecting one in five Americans, the global surge in skin conditions like acne, psoriasis, and eczema—now impacting up to a quarter of children and young adults—reminds us that our skin's health navigates a complex landscape where prevention, early detection, and ongoing research are vital for everyone under the sun.

Market Trends and Industry Growth

The global dermatology market was valued at approximately $16.4 billion in 2022
Laser skin resurfacing procedures increased by 5% globally in 2022
The use of biologic drugs for psoriasis treatment has increased by over 250% in the last decade
The global market for anti-aging dermatology products is projected to reach $14 billion by 2027
Augmentation of the lips with fillers has increased by 60% globally from 2020 to 2022
The global market for medical dermatology drugs was valued at around $10 billion in 2021
The number of dermatology apps increased by over 300% during the COVID-19 pandemic, reflecting a shift towards teledermatology
The market for laser therapy devices in dermatology is projected to reach $2.2 billion by 2025
There is an increasing trend of using cosmeceuticals in dermatology, with the global market expected to reach $55 billion by 2025
The average waiting time for dermatology appointments in the U.S. is about 30 days, often leading patients to seek alternative solutions
The global dermatology-related telemedicine market is expected to grow at a CAGR of 16% from 2022 to 2030
The global anti-aging dermatology market is projected to grow at a CAGR of approximately 7% from 2023 to 2030, reaching over $25 billion
The global market for clinical dermatology devices is expected to reach $3 billion by 2025, driven largely by advances in aesthetic treatments
The use of chemical peels increased by 20% during the COVID-19 pandemic, as patients sought non-invasive anti-aging treatments

Market Trends and Industry Growth Interpretation

Amidst a booming $16.4 billion global dermatology market and a 300% surge in teledermatology apps, rapid advancements in biologics, cosmetic fillers, and laser tech reflect both a societal obsession with youthful skin and a pressing need to innovate in a landscape where wait times and digital solutions are as critical as the treatments themselves.

Risk Factors, Demographics, and Preventive Measures

UV exposure increases the risk of melanoma by approximately 20 times in individuals who have had significant sunburns
The use of sunscreens with SPF 30 or higher can reduce skin cancer risk by approximately 50%

Risk Factors, Demographics, and Preventive Measures Interpretation

Without a shield, a single sunburn can elevate your melanoma risk twentyfold, but with SPF 30 or higher, you halve your chances—suggesting that a little sunscreens’ savvy could save your skin from a catastrophic chart twist.

Treatment Modalities and Therapeutics

The average cost of treating actinic keratosis in the U.S. ranges from $150 to $400 per lesion
The use of topical corticosteroids is one of the most common dermatological treatments, with over 250 million prescriptions annually in the U.S.
The use of topical retinoids in dermatology increased by roughly 45% over the last decade, mainly for acne and anti-aging

Treatment Modalities and Therapeutics Interpretation

With millions battling skin issues, the staggering costs of treating lesions, the widespread reliance on corticosteroids, and the burgeoning popularity of retinoids underscore dermatology’s dual challenge of managing skin health while balancing affordability and evolving treatment trends.